# Signals Article on Putative Target Q5SW96 for Familial Hypercholesterolemia
Background
The protein encoded by the putative target Q5SW96, known as "Uncharacterized protein," has surfaced as a candidate of interest in the context of familial hypercholesterolemia (FH), a genetic disorder characterized by significantly elevated levels of cholesterol in the blood. This condition is primarily caused by mutations affecting lipid metabolism, leading to an increased risk of cardiovascular disease. Given the potential role of Q5SW96 in cholesterol regulation, further investigation into its expression and function could provide valuable insights for therapeutic development in FH.Data-mining rationale
In our analysis, we cross-referenced reviewed human entries from UniProt for "familial hypercholesterolemia" against 11 microarray datasets available in the NCBI Gene Expression Omnibus (GEO). The candidate Q5SW96 was identified in several expression-profiling studies; however, it notably lacks any registered Phase 1 or higher clinical program. This finding suggests a potential gap in the exploration of Q5SW96's role in FH, indicating that it may have been overlooked in previous research.Why prior analyses may have missed this
Many of the GEO datasets utilized in our analysis predate the implementation of modern empirical-Bayes statistical methods, such as the limma package, which allows for more robust multiple-testing corrections. As a result, the expression data related to Q5SW96 may not have been adequately analyzed, leading to its underappreciation in the context of familial hypercholesterolemia. The absence of advanced statistical techniques could have obscured significant findings that warrant further exploration.Reasoning for further validation
To substantiate the potential role of Q5SW96 in familial hypercholesterolemia, we propose the following experimental approaches:1. **Re-analyze matched GEO datasets**: Utilize the limma package with Benjamini-Hochberg false discovery rate (FDR) correction set to < 0.05 to identify differentially expressed genes associated with FH, including Q5SW96.
2. **Validate top differentially-expressed genes**: Conduct quantitative PCR (qPCR) in an independent cohort to confirm the expression levels of Q5SW96 and other top candidates identified in the re-analysis.
3. **Check tissue specificity**: Utilize resources such as the Genotype-Tissue Expression (GTEx) project and the Human Protein Atlas to assess the tissue-specific expression patterns of Q5SW96, which may provide insights into its functional relevance in lipid metabolism.
4. **Run pathway context analyses**: Employ tools like STRING and OmniPath to elucidate the potential pathways in which Q5SW96 is involved, helping to contextualize its role in familial hypercholesterolemia.
5. **Assess druggability**: If validation studies confirm the involvement of Q5SW96 in FH, evaluate its druggability using databases such as DGIdb and ChEMBL to explore potential therapeutic interventions.
References
- UniProt: Q5SW96, Q8NBP7, P04114, P01130, Q9H222
- GEO Accession: GDS:200265997, GDS:200136798, GDS:200136797, GDS:200136792, GDS:200025425